1882 Participants Needed

H-HOPE Intervention for Premature Infants

Recruiting at 3 trial locations
CW
RW
Overseen ByRosemary White-Traut, PhD,RN,FAAN
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Medical College of Wisconsin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I need to stop my current medications to join the trial?

The trial protocol does not specify whether participants need to stop taking their current medications. However, since the trial focuses on behavioral interventions for infants and their parents, it is unlikely that stopping medications is required. Please consult with the trial coordinators for more specific guidance.

What data supports the idea that H-HOPE Intervention for Premature Infants is an effective treatment?

The available research shows that the H-HOPE Intervention is effective because it is a standardized program that includes both infant-directed and parent-directed components. It has been documented to help with feeding, growth, and development in premature infants. The study aims to make H-HOPE the standard care in multiple neonatal intensive care units, indicating its recognized benefits. Compared to other treatments, H-HOPE focuses on both the infant's needs and parental involvement, which is not commonly provided as routine care in many hospitals.12345

What safety data is available for the H-HOPE Intervention for premature infants?

The provided research does not directly address safety data for the H-HOPE Intervention. However, it mentions that H-HOPE is a standardized behavioral intervention with documented efficacy, suggesting it has been studied for effectiveness. The research also highlights the need for safety monitoring in NICUs, but specific safety data for H-HOPE is not detailed in the abstracts.16789

Is the H-HOPE Intervention a promising treatment for premature infants?

Yes, the H-HOPE Intervention is promising for premature infants. It helps improve feeding, growth, and development, and enhances mother-infant interactions. It also increases the frequency of behaviors that prepare infants for feeding and keeps them more alert, which is important for their development.12101112

What is the purpose of this trial?

This trial tests the H-HOPE program, which helps preterm infants develop through sensory stimulation and supports parents in interacting with their babies. The study aims to see if H-HOPE can be successfully used in different NICUs and if it improves infant health and reduces costs. The results could lead to widespread use of H-HOPE in hospitals. H-HOPE is a standardized behavioral intervention with an infant-directed component designed to optimize developmental trajectories and increase parents' interactive engagement with their infants.

Research Team

RW

Rosemary White-Traut, PhD,RN,FAAN

Principal Investigator

Department of Nursing Research and Evidence-Based Practice Children's Wisconsin

Eligibility Criteria

This trial is for preterm infants born between 23-35 weeks gestational age, now at 31-32 weeks post menstrual age, and their parents. Infants may be on oxygen or IV therapy and previously intubated but must be ready for social interaction. Parents of any background can join; only one infant per multiple births will be analyzed.

Inclusion Criteria

I am either male or female.
The study is looking at two groups of parents and infants: one group is receiving a family intervention called H-HOPE, and the other group is a comparison group. Both parents and infants must meet certain requirements to be eligible for either group. There are also requirements for hospital personnel involved in the study.
I may be on oxygen or receiving treatment through an IV.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Implementation

H-HOPE intervention is implemented in NICUs, including Planning and Engaging, Executing, and Reflecting and Evaluating steps

6 months
Regular NICU visits for implementation activities

Sustaining

Sustaining phase to ensure continued offering of H-HOPE and measure implementation success

6 months

Follow-up

Participants are monitored for effectiveness and safety, including infant growth and acute care visits

6 weeks post-discharge

Treatment Details

Interventions

  • H-HOPE Intervention
Trial Overview The H-HOPE Intervention is being tested to see if it can support early brain development in premature infants by providing stimulation (auditory, tactile, visual, vestibular) and helping parents engage with their babies in NICUs and at home.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: H-HOPE CohortExperimental Treatment1 Intervention
The H-HOPE Cohort will receive the H-HOPE intervention.
Group II: Pre H-HOPE CohortActive Control1 Intervention
The Pre-H-HOPE Comparison Cohort will not receive the H-HOPE intervention, and represents the prior standard (non-HOPE).

H-HOPE Intervention is already approved in United States for the following indications:

🇺🇸
Approved in United States as H-HOPE Intervention for:
  • Supporting early brain maturation, health, and development in preterm infants

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical College of Wisconsin

Lead Sponsor

Trials
645
Recruited
1,180,000+

Children's Hospital and Health System Foundation, Wisconsin

Collaborator

Trials
56
Recruited
93,300+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials
2,103
Recruited
2,760,000+

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+

University of Chicago

Collaborator

Trials
1,086
Recruited
844,000+

Advocate Health Care

Collaborator

Trials
57
Recruited
1,412,000+

Wake Forest University Health Sciences

Collaborator

Trials
1,432
Recruited
2,506,000+

Advocate Aurora Health

Collaborator

Trials
3
Recruited
57,000+

Findings from Research

The H-HOPE intervention, which includes both infant-directed and parent-directed components, aims to standardize behavioral care for preterm infants across five NICUs, potentially improving feeding, growth, and developmental outcomes.
This implementation study uses a structured approach based on the Consolidated Framework for Implementation Research (CFIR) to identify facilitators and barriers to successfully integrating H-HOPE into routine care, with the goal of sustaining its use even after external support ends.
Protocol for implementation of an evidence based parentally administered intervention for preterm infants.White-Traut, R., Brandon, D., Kavanaugh, K., et al.[2023]
A study involving 284 very preterm infants assessed the effectiveness of a home-based developmental education intervention, but by age 5, there were no significant differences in cognitive, behavioral, or motor outcomes among the intervention groups compared to standard care.
Despite some initial advantages observed at 2 years, the benefits of early intervention did not persist by age 5, raising questions about the long-term efficacy of such programs for improving outcomes in very preterm infants.
Randomised trial of parental support for families with very preterm children: outcome at 5 years.Johnson, S., Ring, W., Anderson, P., et al.[2019]
The article explores the concept of hope specifically in parents of critically ill newborns in neonatal intensive care units, highlighting its significance in this challenging context.
It aims to define critical attributes of hope, as well as its antecedents and consequences, providing a comprehensive understanding of how hope functions for these parents during a difficult time.
Hope and parents of the critically ill newborn: a concept analysis.Amendolia, B.[2022]

References

Protocol for implementation of an evidence based parentally administered intervention for preterm infants. [2023]
Randomised trial of parental support for families with very preterm children: outcome at 5 years. [2019]
Hope and parents of the critically ill newborn: a concept analysis. [2022]
Developmental and Interprofessional Care of the Preterm Infant: Neonatal Intensive Care Unit Through High-Risk Infant Follow-up. [2019]
Transmitted Home Oximetry and Duration of Home Oxygen in Premature Infants. [2020]
The neonatal preventable harm index: a high reliability tool. [2018]
Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs. [2021]
Early discharge and hospital-assisted home care is associated with better neurodevelopmental outcome in preterm infants. [2022]
Supporting Play Exploration and Early Development Intervention From NICU to Home: A Feasibility Study. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
Mother-infant interaction improves with a developmental intervention for mother-preterm infant dyads. [2022]
Randomized controlled trial of Family Nurture Intervention in the NICU: assessments of length of stay, feasibility and safety. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Preterm infants' orally directed behaviors and behavioral state responses to the integrated H-HOPE intervention. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security